Select Medical (SEM)
(Delayed Data from NYSE)
$34.09 USD
-0.17 (-0.50%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $34.08 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.09 USD
-0.17 (-0.50%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $34.08 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Zacks News
New Strong Buy Stocks for March 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
5 Excellent GARP Stocks Based on Low PEG Ratio
by Urmimala Biswas
Here are five of the 74 GARP stocks that qualify the screening.
Select Medical (SEM) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Select Medical (SEM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Select Medical (SEM) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect solid performances by its Critical Illness Recovery and Rehabilitation Hospital segments.
Encompass Health (EHC) Unveils Plans to Expand in Maryland
by Zacks Equity Research
Encompass Health's (EHC) plans to construct a hospital is indicative of the company's efforts to offer improved healthcare services in southern Maryland.
Earnings Preview: Select Medical (SEM) Q4 Earnings Expected to Decline
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Select Medical (SEM) Rides on a Diversified Business Profile
by Zacks Equity Research
Select Medical's (SEM) supremacy in a fragmented market and its affordable healthcare services in each of its business segments bode well for the long haul.
3 Health Insurers That Crushed S&P YTD, Set to Rise Further
by Srijita Guha
We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.
Is Select Medical (SEM) a Suitable Stock for Value Investors?
by Zacks Equity Research
Let's see if Select Medical (SEM) stock is a good choice for value-oriented investors right now from multiple angles.
Improving Patient Volumes Aid Select Medical's (SEM) Prospects
by Zacks Equity Research
Recovery in patient volumes owing to relaxation of government-imposed constraints is gradually restoring the patient admissions, thereby reinstating Select Medical (SEM) on the growth path.
Select Medical's (SEM) Q3 Earnings Beat Mark, Improve Y/Y
by Zacks Equity Research
Select Medical's (SEM) third-quarter 2020 earnings gain traction from better revenues at its Critical Illness Recovery and Rehabilitation Hospital segments.
Select Medical (SEM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 86.67% and 5.24%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Select Medical (SEM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Universal Health (UHS) to Report Q3 Results: What to Expect
by Zacks Equity Research
Universal Health's (UHS) third-quarter earnings results are likely to reflect depressed revenues and weak admissions.
Centene's (CNC) Q3 Earnings Improve Y/Y on High Revenues
by Zacks Equity Research
Centene's (CNC) third-quarter results reflect higher revenues and managed care membership.
Anthem (ANTM) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings results are likely to reflect elevated costs and a softness in Commercial business line.
Will Covid-Led Higher Demand Aid Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
A surge in demand for virtual health care services is likely to have contributed to Teladoc's (TDOC) earnings in Q3
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Ranked Growth Stocks to Buy for September 29th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 29th
Select Medical Enters Into Joint Venture With Rush University
by Zacks Equity Research
Select Medical (SEM) forms a joint venture with Rush University to manage healthcare operations at facilities in Chicago and Northwest Indiana area.
Centene (CNC) Offers Senior Unsecured Notes Valued $2.2B
by Zacks Equity Research
Centene (CNC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY
by Zacks Equity Research
Zacks.com featured highlights include: LZB, SEM, UCTT, QFIN and BERY
5 Must-Buy Stocks Offering High Earnings Yield
by Rimmi Singhi
The earnings potential of a stock is an important consideration while making investment decisions. This makes the earnings yield ratio a handy tool for stock selection.
Top Ranked Growth Stocks to Buy for September 21st
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 21st
Top Ranked Growth Stocks to Buy for September 17th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 17th